Literature DB >> 894033

Purification of C3b inactivator and demonstration of its two polypeptide chain structure.

D T Fearon.   

Abstract

C3b inactivator (C3bINA) was isolated from plasma by sequential ammonium sulfate gradient solubilization, anion exchange chromatography, gel filtration, and repeat ammonium sulfate gradient solubilization. The final product was pure as assessed by alkaline disc gel electrophoresis, isoelectric focusing, and SDS polyacrylamide gel electrophoresis, and elicited a monospecific rabbit antiserum. The normal serum concentration of C3bINA was found to be 53 +/- 9 microgram/ml (mean +/- S.D.). Heterogeneity of purified C3bINA was apparent on alkaline disc gel electrophoresis and isoelectric focusing, but not with SDS polyacrylamide gel electrophoresis and thus is attributed to forms of C3bINA that differ in charge rather than in size. SDS polyacrylamide gel electrophoresis of unreduced, alkylated C3bINA yielded a single stained band with an apparent m.w. of 93,000, whereas the reduced protein demonstrated two bands of 55,000 and 42,000 m.w., thereby establishing a composition of two disulfide-linked polypeptide chains for C3bINA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894033

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Analysis of binding sites on complement factor I using artificial N-linked glycosylation.

Authors:  Jose I Sanchez-Gallego; Tom W L Groeneveld; Stefanie Krentz; Sara C Nilsson; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

2.  In vivo binding of circulating immune complexes by C3b receptors (CR1) of transfused erythrocytes.

Authors:  Y Inada; M Kamiyama; T Kanemitsu; H Ikegami; K Watanabe; W S Clark; Y Asai
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

3.  Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation.

Authors:  J Minta; M Fung
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

4.  Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3.

Authors:  K Nilsson Ekdahl; B Nilsson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Prevention of immune precipitation by purified components of the alternative pathway.

Authors:  J K Naama; E Holme; E Hamilton; K Whaley
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.

Authors:  M R Daha; A Gorter; P J Leijh; N Klar; L A van Es
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

8.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

9.  Characterization of alternative pathway inhibition by a serum derived, low molecular weight complement inhibitor.

Authors:  P J Baker; C J Parker; S G Osofsky
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.

Authors:  P J Baker; S G Osofsky
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.